- Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy2023 | 1. lékařská fakulta, Přírodovědecká fakulta, 2. lékařská fakulta
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy2017 | 1. lékařská fakulta
- Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy2010 | 3. lékařská fakulta